← Back to Patent Explorer
US5120535A Expired / Lapsed US ⏱️ 0.0 years remaining

Oncostatin M and novel compositions having anti-neoplastic activity

Assignee: Oncogen LP
•
Filing: 1987-05-04
•
Granted: 1992-06-09
•
Expires: 2007-05-04
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Novel compositions are provided for modulating growth, particularly of tumor cells, which compositions are combinations of Oncostatin M, and one or both of transforming growth factors or γ-interferons, or analogs thereof. In addition, a novel transforming growth factor is provided, designated TGF-β2, as well as methods for its preparation.

Inventors

  • 👤 Hans Marquardt
  • 👤 Joyce M. Zarling
  • 👤 Mohammed Shoyab
  • 👤 Marcia B. Hanson
  • 👤 Mario N. Lioubin
  • 👤 Thomas J. Brown
  • 👤 Tatsuhiko Ikeda

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-23 12:25
CPC Classifications
C; C07; C07K; C07K14/00; C07K14/435; C07K14/52; A; A61; A61K; A61K38/00; A61K38/16; A61K38/17; A61K38/19; A61K38/20; A61K38/204; A61K38/21; A61K38/217; C07K14/475; C07K14/495; C07K16/00; C07K16/18; C07K16/22; C07K16/24; C07K2319/00; C07K2319/70; C07K2319/74; C07K2319/75

Claims Analysis

Total Claims: 3
Claim 1
Independent Claim 36 words
A neoplastic cell proliferation inhibiting composition comprising a cell proliferation inhibiting amount of Oncostatin M in combination with an adjunctive agent consisting of at least one of interferon-γ, transforming growth factor in a physiologically acceptable carrier.
Claim 2
Dependent Claim 36 words
A neoplastic cell proliferation inhibiting composition comprising a cell proliferation inhibiting amount of Oncostatin M in combination with an adjunctive agent consisting of at least one of interferon-γ, transforming growth factor in a physiologically acceptable carrier.
Claim 3
Dependent Claim 20 words
A composition according to claim 1, wherein said Oncostatin M is at least 25 weight percent of the inhibiting combination.

References Cited (Backward Citations)

EP0169016A2 Cited
US4737580A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1995-06-09 1995-12-09 1996-06-09 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1999-06-09 1999-12-09 2000-06-09 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2003-06-09 2003-12-09 2004-06-09 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag